Oxidative Stress in Melanoma: Beneficial Antioxidant and Pro-Oxidant Therapeutic Strategies
Cancers · 02.06.2023 · 15 (11) · 3038
DOI: 10.3390/cancers15113038 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 02.06.2023. Verfasst von Alyssa L Becker und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, College of Pharmacy, Oregon State University (OSU), Corvallis, OR 97331, USA. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 151 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: United States Department of Defense, Department of Defense.
Abstract (Originalsprache)
Cutaneous melanoma ranks as the fifth most common cancer in the United States and represents one of the deadliest forms of skin cancer. While recent advances in systemic targeted therapies and immunotherapies have positively impacted melanoma survival, the survival rate of stage IV melanoma remains at a meager 32%. Unfortunately, tumor resistance can impede the effectiveness of these treatments. Oxidative stress is a pivotal player in all stages of melanoma progression, with a somewhat paradoxical function that promotes tumor initiation but hinders vertical growth and metastasis in later disease. As melanoma progresses, it employs adaptive mechanisms to lessen oxidative stress in the tumor environment. Redox metabolic rewiring has been implicated in acquired resistance to BRAF/MEK inhibitors. A promising approach to enhance the response to therapy involves boosting intracellular ROS production using active biomolecules or targeting enzymes that regulate oxidative stress. The complex interplay between oxidative stress, redox homeostasis, and melanomagenesis can also be leveraged in a preventive context. The purpose of this review is to provide an overview of oxidative stress in melanoma, and how the antioxidant system may be manipulated in a therapeutic context for improved efficacy and survival.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, College of Pharmacy, Oregon State University (OSU), Corvallis, OR 97331, USA.
- John A. Burns School of Medicine, University of Hawai'i at Mānoa, Honolulu, HI 96813, USA.
- Knight Cancer Institute, Oregon Health & Science University (OHSU), Portland, OR 97239, USA.
- Department of Biochemistry and Biophysics, Oregon State University (OSU), Corvallis, OR 97331, USA.
- Linus Pauling Science Center, Oregon State University (OSU), Corvallis, OR 97331, USA.
- Department of Dermatology, Oregon Health & Science University (OHSU), Portland, OR 97239, USA.
ORCID-Profile: Arup K Indra
Förderung
- United States Department of Defense
- Department of Defense
Zitieren
APA
Becker, A. L., & Indra, A. K. (2023). Oxidative Stress in Melanoma: Beneficial Antioxidant and Pro-Oxidant Therapeutic Strategies. Cancers, 15(11), 3038. https://doi.org/10.3390/cancers15113038
Vancouver
Becker AL, Indra AK. Oxidative Stress in Melanoma: Beneficial Antioxidant and Pro-Oxidant Therapeutic Strategies. Cancers. 2023;15(11):3038. doi:10.3390/cancers15113038
BibTeX
@article{Becker2023,
author = {Becker, Alyssa L and Indra, Arup K},
title = {Oxidative Stress in Melanoma: Beneficial Antioxidant and Pro-Oxidant Therapeutic Strategies},
journal = {Cancers},
year = {2023},
volume = {15},
number = {11},
pages = {3038},
doi = {10.3390/cancers15113038}
}
EUVIMED